Sunday, 11 December 2011

Apo-Selin




Apo-Selin may be available in the countries listed below.


Ingredient matches for Apo-Selin



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Apo-Selin in the following countries:


  • Poland

International Drug Name Search

Wednesday, 7 December 2011

Antimizol




Antimizol may be available in the countries listed below.


Ingredient matches for Antimizol



Clotrimazole

Clotrimazole is reported as an ingredient of Antimizol in the following countries:


  • Venezuela

International Drug Name Search

Tuesday, 6 December 2011

Numbon




Numbon may be available in the countries listed below.


Ingredient matches for Numbon



Nitrazepam

Nitrazepam is reported as an ingredient of Numbon in the following countries:


  • Israel

International Drug Name Search

Sunday, 4 December 2011

Chanazine




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Chanazine



Xylazine

Xylazine is reported as an ingredient of Chanazine in the following countries:


  • Austria

  • Ireland

  • Netherlands

  • Portugal

  • South Africa

  • United Kingdom

Xylazine hydrochloride (a derivative of Xylazine) is reported as an ingredient of Chanazine in the following countries:


  • United States

International Drug Name Search

Metformin Beacons




Metformin Beacons may be available in the countries listed below.


Ingredient matches for Metformin Beacons



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformin Beacons in the following countries:


  • Singapore

International Drug Name Search

Friday, 2 December 2011

Ceramil




Ceramil may be available in the countries listed below.


Ingredient matches for Ceramil



Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Ceramil in the following countries:


  • Greece

International Drug Name Search

Totalprost




Totalprost may be available in the countries listed below.


Ingredient matches for Totalprost



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Totalprost in the following countries:


  • Hungary

International Drug Name Search

Wednesday, 23 November 2011

Metoclopramide HCl




Ingredient matches for Metoclopramide HCl



Metoclopramide

Metoclopramide dihydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Metoclopramide HCl in the following countries:


  • United States

International Drug Name Search

Tuesday, 22 November 2011

Sempera




Sempera may be available in the countries listed below.


Ingredient matches for Sempera



Itraconazole

Itraconazole is reported as an ingredient of Sempera in the following countries:


  • Germany

International Drug Name Search

Serelan




Serelan may be available in the countries listed below.


Ingredient matches for Serelan



Mianserin

Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Serelan in the following countries:


  • Luxembourg

International Drug Name Search

Sunday, 20 November 2011

Bisolex




Bisolex may be available in the countries listed below.


Ingredient matches for Bisolex



Bromhexine

Bromhexine is reported as an ingredient of Bisolex in the following countries:


  • Bosnia & Herzegowina

  • Croatia (Hrvatska)

International Drug Name Search

Tuesday, 15 November 2011

Cosy




Cosy may be available in the countries listed below.


Ingredient matches for Cosy



Domperidone

Domperidone is reported as an ingredient of Cosy in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 13 November 2011

Ossibiotic




Ossibiotic may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ossibiotic



Oxytetracycline

Oxytetracycline is reported as an ingredient of Ossibiotic in the following countries:


  • Italy

International Drug Name Search

Saturday, 12 November 2011

Belimumab


Pronunciation: be-LIM-ue-mab
Generic Name: Belimumab
Brand Name: Benlysta


Belimumab is used for:

Treating certain patients with systemic lupus erythematosus (SLE). It may also be used for other conditions as determined by your doctor.


Belimumab is a B-lymphocyte stimulator (BLyS)-specific inhibitor. Patients with lupus often have high levels of a certain protein in their blood. Belimumab works by limiting the activity of that protein.


Do NOT use Belimumab if:


  • you are allergic to any ingredient in Belimumab

  • you have severe, active central nervous system lupus

  • you have certain severe kidney problems associated with lupus (severe, active lupus nephritis)

  • you are using another biologic medicine (eg, etanercept, infliximab, immune globulin)

  • you are receiving cyclophosphamide as an injection into your vein (intravenous [IV])

Contact your doctor or health care provider right away if any of these apply to you.



Before using Belimumab:


Some medical conditions may interact with Belimumab. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of a long-term infection, an infection that keeps coming back, tuberculosis (TB) infection or a positive TB skin test, or hepatitis B infection

  • if you have an infection, open cuts or sores on your body, flu-like symptoms or other signs of infection (eg, fever; chills; cough; warm, red, or painful skin), or are using medicine to treat an infection

  • if you have a history of cancer or heart problems

  • if you have a history of mental or mood problems (eg, depression), or suicidal thoughts or actions

  • if you have recently received a vaccine or are scheduled to receive a vaccine

Some MEDICINES MAY INTERACT with Belimumab. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Other biologic medicines (eg, etanercept, infliximab, immune globulin), IV cyclophosphamide, or monoclonal antibodies (eg, certolizumab, denosumab) because the risk of their side effects may be increased by Belimumab

This may not be a complete list of all interactions that may occur. Ask your health care provider if Belimumab may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Belimumab:


Use Belimumab as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Belimumab comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Belimumab refilled.

  • Belimumab is usually given as an injection into the vein at your doctor's office, hospital, or clinic.

  • You may receive another medicine before each treatment with Belimumab to decrease the chance of an allergic reaction. Discuss any questions with your doctor.

  • Do not use Belimumab if it contains particles, is cloudy or discolored, or if the syringe or pen is cracked or damaged.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Belimumab, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Belimumab.



Important safety information:


  • Do NOT use more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Belimumab may lower the ability of your body to fight infection and may increase the risk of severe or fatal infection. Avoid contact with people who have colds, flu, shingles, or other infections. Tell your doctor right away if you notice signs of infection like fever, sore throat, rash, or chills.

  • Treatment with medicines similar to Belimumab may increase in the risk of developing cancer. It is possible that treatment with Belimumab may also increase this risk. Discuss any questions or concerns with your doctor.

  • Some patients using Belimumab reported mental or mood changes (eg, anxiety, depression) and suicidal thoughts or actions. The majority of these patients had a history of depression or other serious mental or mood problems. It is unknown if Belimumab is associated with an increased risk of these events. Tell your doctor right away if you develop anxiety, depression, severe or persistent trouble sleeping, suicidal thoughts or actions, or any other mental or mood changes.

  • Tell your doctor or dentist that you take Belimumab before you receive any medical or dental care, emergency care, or surgery.

  • Do not receive a live vaccine (eg, measles, mumps) while you are using Belimumab or for 30 days before you begin using it. Talk with your doctor before you receive any vaccine.

  • Belimumab may not work as well in black patients. Contact your doctor if your symptoms do not improve or if they become worse.

  • Women who may become pregnant should use effective birth control while using Belimumab and for 4 months after the last treatment. Check with your doctor if you have questions about effective birth control.

  • Belimumab should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Belimumab while you are pregnant. It is not known if Belimumab is found in breast milk. Do not breast-feed while using Belimumab.


Possible side effects of Belimumab:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; headache; nausea; pain in the arm or leg; sinus inflammation; stomach pain; stuffy or runny nose; trouble sleeping.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; wheezing; unusual hoarseness); fainting; mental or mood changes (eg, anxiety, depression); muscle pain or weakness; severe or persistent headache or dizziness; severe or persistent trouble sleeping; suicidal thoughts or actions; symptoms of heart problems (eg, chest pain or discomfort, shortness of breath, slow heartbeat, dizziness, cold sweats); symptoms of infection (eg, fever, chills, or persistent sore throat; persistent cough; flu-like symptoms; warm, red, or painful skin; open sore that does not heal; increased or painful urination).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Belimumab side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Belimumab:

Belimumab is usually handled and stored by a health care provider. If you are using Belimumab at home, store Belimumab as directed by your pharmacist or health care provider. Keep Belimumab out of the reach of children and away from pets.


General information:


  • If you have any questions about Belimumab, please talk with your doctor, pharmacist, or other health care provider.

  • Belimumab is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Belimumab. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Belimumab resources


  • Belimumab Side Effects (in more detail)
  • Belimumab Use in Pregnancy & Breastfeeding
  • Belimumab Drug Interactions
  • Belimumab Support Group
  • 0 Reviews for Belimumab - Add your own review/rating


  • Belimumab Professional Patient Advice (Wolters Kluwer)

  • belimumab Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benlysta Prescribing Information (FDA)

  • Benlysta Consumer Overview



Compare Belimumab with other medications


  • Systemic Lupus Erythematosus

Friday, 11 November 2011

Amitriptilina L.CH.




Amitriptilina L.CH. may be available in the countries listed below.


Ingredient matches for Amitriptilina L.CH.



Amitriptyline

Amitriptyline is reported as an ingredient of Amitriptilina L.CH. in the following countries:


  • Chile

International Drug Name Search

Thursday, 3 November 2011

Amoxicilina Generifarma




Amoxicilina Generifarma may be available in the countries listed below.


Ingredient matches for Amoxicilina Generifarma



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilina Generifarma in the following countries:


  • Spain

International Drug Name Search

Thursday, 27 October 2011

Levacol




Levacol may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Levacol



Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Levacol in the following countries:


  • Netherlands

International Drug Name Search

Thursday, 20 October 2011

Domperidon Alternova




Domperidon Alternova may be available in the countries listed below.


Ingredient matches for Domperidon Alternova



Domperidone

Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Domperidon Alternova in the following countries:


  • Austria

  • Denmark

International Drug Name Search

Wednesday, 19 October 2011

Akriderm




Akriderm may be available in the countries listed below.


Ingredient matches for Akriderm



Betamethasone

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Akriderm in the following countries:


  • Russian Federation

International Drug Name Search

Monday, 17 October 2011

Voltaren Ophtha




Voltaren Ophtha may be available in the countries listed below.


Ingredient matches for Voltaren Ophtha



Diclofenac

Diclofenac is reported as an ingredient of Voltaren Ophtha in the following countries:


  • Tunisia

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Voltaren Ophtha in the following countries:


  • Australia

  • Austria

  • Canada

  • Czech Republic

  • Denmark

  • Finland

  • Germany

  • Hungary

  • Iceland

  • Indonesia

  • Israel

  • Latvia

  • Lithuania

  • Luxembourg

  • New Zealand

  • Norway

  • South Africa

  • Sweden

  • Switzerland

  • Thailand

  • Turkey

International Drug Name Search

Sunday, 16 October 2011

Kenalog




In the US, Kenalog (triamcinolone topical) is a member of the drug class topical steroids and is used to treat Atopic Dermatitis, Dermatitis, Lichen Planus and Psoriasis.

US matches:

  • Kenalog

  • Kenalog Aerosol Solution

  • Kenalog Cream

  • Kenalog Lotion

  • Kenalog-10 Suspension

  • Kenalog-40 Suspension

  • Kenalog-10 injection

  • Kenalog-40 injection

  • Kenalog Ointment

  • Kenalog Spray

  • Kenalog-10

  • Kenalog-40

  • Kenalog Orabase

UK matches:

  • Kenalog Intra-articular / Intramuscular Injection (SPC)
  • Kenalog Intra-Articular/Intramuscular Injection (E. R. Squibb & Sons Limited) (SPC)
  • Kenalog Intra-Articular/Intramuscular Injection (E. R. Squibb & Sons Limited) (SPC)

Ingredient matches for Kenalog



Ketoconazole

Ketoconazole is reported as an ingredient of Kenalog in the following countries:


  • Ethiopia

Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Kenalog in the following countries:


  • Australia

  • Bahrain

  • Canada

  • Croatia (Hrvatska)

  • Denmark

  • Ethiopia

  • Georgia

  • Hungary

  • Iceland

  • Ireland

  • Japan

  • Kenya

  • Latvia

  • Lithuania

  • New Zealand

  • Russian Federation

  • Serbia

  • Singapore

  • Slovenia

  • Tanzania

  • Uganda

  • United Kingdom

  • United States

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 14 October 2011

Restasis



Generic Name: cyclosporine (Ophthalmic route)

sye-kloe-SPOR-een

Commonly used brand name(s)

In the U.S.


  • Restasis

Available Dosage Forms:


  • Emulsion

Therapeutic Class: Anti-Inflammatory


Pharmacologic Class: Calcineurin Inhibitor


Uses For Restasis


Cyclosporine belongs to a class of medicines known as immunosuppressants. It is used to increase tear production in people who have a certain eye condition.


This medicine is available only with your doctor's prescription.


Before Using Restasis


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Cyclosporine eye drops have only been studied in children age 16 and older. Discuss with your child's doctor the good that this medicine may do as well as the risks of using it.


Geriatric


This medicine has been tested and has not been shown to cause different side effects or problems in older people than it does in younger adults.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Current eye infections or

  • Hypersensitivity to cyclosporine or any ingredients in cyclosporine—This medicine should not be used if you have these conditions.

  • History of herpes infection of your cornea—Caution should be used with this medicine if you have this condition.

  • If you are a contact lens user—Patients with decreased tear production should not wear contacts.

Proper Use of Restasis


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


You should not use cyclosporine eye drops if you have contact lenses in your eyes. Remove your contact lenses before putting the medicine in your eyes. You can reinsert your contacts 15 minutes after you put the medicine in your eyes.


You may use cyclosporine eye drops if you use artificial tears. However, after putting in your artificial tears, you must wait 15 minutes before putting the cyclosporine eye drops into your eyes.


Do not shake the vial. Instead, rotate the vial gently back and forth before use.


Use this medicine only once, then throw away any unused drug.


To use:


  • First, wash your hands. Tilt the head back and pressing your finger gently on the skin just beneath the lower eyelid, pull the lower eyelid away from the eye to make a space. Drop the medicine into this space. Let go of the eyelid and gently close the eyes. Do not blink.

  • If you think you did not get the drop of medicine into your eye properly, use another drop.

  • Immediately after using the eye drops, wash your hands to remove any medicine that may be on them.

  • To keep the medicine as germ free as possible, do not touch the applicator tip to any surface (including the eye).

  • For ophthalmic emulsion (eye drops) dosage form:
    • For dry eyes:
      • Adults—Instill one drop into the eye every 12 hours.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Restasis


It is very important that your doctor check you at regular visits. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it.


If your symptoms do not improve or if they become worse, check with your doctor.


This medicine may cause blurred vision or other vision problems. If any of these occur, do not drive, use machines, or do anything else that could be dangerous if you are not able to see well.


Restasis Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More Common
  • Burning or other discomfort of the eye

Less common
  • Blurred vision

  • clear or yellow fluid from eye

  • difficulty reading

  • eye pain

  • feeling of having something in the eye

  • halos around lights

  • itching skin

  • redness of the white part of your eyes or inside of your eyelids

  • sticky or matted eyelashes

  • stinging

  • watery eye

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Restasis side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Restasis resources


  • Restasis Side Effects (in more detail)
  • Restasis Use in Pregnancy & Breastfeeding
  • Restasis Support Group
  • 1 Review for Restasis - Add your own review/rating


  • Restasis Prescribing Information (FDA)

  • Restasis eent Monograph (AHFS DI)

  • Restasis Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Restasis Consumer Overview



Compare Restasis with other medications


  • Keratoconjunctivitis Sicca

Wednesday, 12 October 2011

Aciclovir PHC




Aciclovir PHC may be available in the countries listed below.


Ingredient matches for Aciclovir PHC



Acyclovir

Aciclovir is reported as an ingredient of Aciclovir PHC in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 2 October 2011

Isotretinoine A




Isotretinoine A may be available in the countries listed below.


Ingredient matches for Isotretinoine A



Isotretinoin

Isotretinoin is reported as an ingredient of Isotretinoine A in the following countries:


  • Netherlands

International Drug Name Search

Monday, 26 September 2011

Canestene Gyn




Canestene Gyn may be available in the countries listed below.


Ingredient matches for Canestene Gyn



Clotrimazole

Clotrimazole is reported as an ingredient of Canestene Gyn in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Saturday, 10 September 2011

Duopack




Duopack may be available in the countries listed below.


Ingredient matches for Duopack



Salbutamol

Salbutamol is reported as an ingredient of Duopack in the following countries:


  • Argentina

International Drug Name Search

Friday, 9 September 2011

Arteoptic




Arteoptic may be available in the countries listed below.


Ingredient matches for Arteoptic



Carteolol

Carteolol hydrochloride (a derivative of Carteolol) is reported as an ingredient of Arteoptic in the following countries:


  • Belgium

  • Czech Republic

  • Germany

  • Hong Kong

  • Luxembourg

  • Netherlands

  • Poland

  • Portugal

  • Slovakia

  • Spain

  • Switzerland

  • Taiwan

  • Thailand

International Drug Name Search

Wednesday, 17 August 2011

Ramipril Sumol




Ramipril Sumol may be available in the countries listed below.


Ingredient matches for Ramipril Sumol



Ramipril

Ramipril is reported as an ingredient of Ramipril Sumol in the following countries:


  • Spain

International Drug Name Search

Monday, 8 August 2011

Pramevan




Pramevan may be available in the countries listed below.


Ingredient matches for Pramevan



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pramevan in the following countries:


  • Japan

International Drug Name Search

Thursday, 4 August 2011

Paget's Disease Medications


Definition of Paget's Disease: This is a disease of bone that initially results in the excessive resorption of bone

Drugs associated with Paget's Disease

The following drugs and medications are in some way related to, or used in the treatment of Paget's Disease. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Paget's Disease

  • Osteopetrosis (1 drug)





Drug List:

Saturday, 23 July 2011

Hamilton Dry Skin Treatment Cream




Hamilton Dry Skin Treatment Cream may be available in the countries listed below.


Ingredient matches for Hamilton Dry Skin Treatment Cream



Urea

Urea is reported as an ingredient of Hamilton Dry Skin Treatment Cream in the following countries:


  • Australia

International Drug Name Search

Thursday, 21 July 2011

Zorstat




Zorstat may be available in the countries listed below.


Ingredient matches for Zorstat



Simvastatin

Simvastatin is reported as an ingredient of Zorstat in the following countries:


  • Slovenia

International Drug Name Search

Tuesday, 19 July 2011

Moxotens




Moxotens may be available in the countries listed below.


Ingredient matches for Moxotens



Moxonidine

Moxonidine is reported as an ingredient of Moxotens in the following countries:


  • South Africa

International Drug Name Search

Monday, 11 July 2011

Fertavid




Fertavid may be available in the countries listed below.


Ingredient matches for Fertavid



Follicle Stimulating Hormone

Follitropin Beta is reported as an ingredient of Fertavid in the following countries:


  • Switzerland

International Drug Name Search

Monday, 4 July 2011

Okt




Okt may be available in the countries listed below.


Ingredient matches for Okt



Muromonab-Cd3

Muromonab-CD3 is reported as an ingredient of Okt in the following countries:


  • Turkey

International Drug Name Search

Friday, 1 July 2011

Clinadol




Clinadol may be available in the countries listed below.


Ingredient matches for Clinadol



Flurbiprofen

Flurbiprofen is reported as an ingredient of Clinadol in the following countries:


  • Argentina

International Drug Name Search

Sunday, 26 June 2011

OxyIR


Pronunciation: ox-ee-KOE-dohn
Generic Name: Oxycodone
Brand Name: Examples include OxyIR and Roxicodone


OxyIR is used for:

Treating moderate to severe pain. It may be used before surgery to sedate the patient and reduce fear. It may also be used for other conditions as determined by your doctor.


OxyIR is a narcotic pain reliever. It works by dulling the pain perception center in the brain. It may also affect other body systems (eg, respiratory and circulatory systems) at higher doses.


Do NOT use OxyIR if:


  • you are allergic to any ingredient in OxyIR or any other oxycodone- or morphine-related medicine (eg, codeine)

  • you are taking sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

  • you have severe bowel motility problems (eg, paralytic ileus) or severe diarrhea associated with antibiotic use (pseudomembranous colitis)

  • you have severely slow or difficult breathing or severe asthma, or you are having an asthma attack

Contact your doctor or health care provider right away if any of these apply to you.



Before using OxyIR:


Some medical conditions may interact with OxyIR. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of asthma, chronic obstructive pulmonary disease (COPD), or other lung or breathing problems

  • if you have a history of recent head injury, increased pressure in the brain, growths in the brain (eg, tumors), or seizures

  • if you have a history of heart problems, low blood pressure, liver or kidney problems, an underactive thyroid, adrenal gland problems (eg, Addison disease), stomach or bowel problems, gallbladder problems, inflammation of the pancreas, a blockage of the bladder or bowel, an enlarged prostate, or the blood disease porphyria

  • if you have a history of drug or alcohol abuse, mood or mental problems, or suicidal thoughts or behavior

Some MEDICINES MAY INTERACT with OxyIR. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Cimetidine, furazolidone, MAO inhibitors (eg, phenelzine), phenothiazines (eg, chlorpromazine), or sodium oxybate (GHB) because the risk of side effects such as severe drowsiness, slow or difficult breathing, confusion, and seizures may be increased

  • Buprenorphine, butorphanol, nalbuphine, naltrexone, or pentazocine because the effectiveness of OxyIR may be decreased

This may not be a complete list of all interactions that may occur. Ask your health care provider if OxyIR may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use OxyIR:


Use OxyIR as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take OxyIR by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • If you miss a dose of OxyIR and you are using it regularly, use it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use OxyIR.



Important safety information:


  • OxyIR may cause dizziness or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use OxyIR with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using OxyIR; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • OxyIR may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Tell your doctor or dentist that you take OxyIR before you receive any medical or dental care, emergency care, or surgery.

  • Use OxyIR with caution in the ELDERLY; they may be more sensitive to its effects.

  • OxyIR should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY AND BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using OxyIR while you are pregnant. OxyIR is found in breast milk. Do not breast-feed while taking OxyIR.

When used for long periods of time or at high doses, OxyIR may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if OxyIR stops working well. Do not take more than prescribed.


Some people who use OxyIR for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. If you suddenly stop taking OxyIR, you may experience WITHDRAWAL symptoms including anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea; vomiting; pain; rigid muscles; rapid heartbeat; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping.



Possible side effects of OxyIR:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; dizziness; drowsiness; headache; nausea; sleeplessness; vomiting; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; difficulty urinating; fast or slow heartbeat; seizures; severe dizziness, lightheadedness, or fainting; slowed or difficult breathing; tremor; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: OxyIR side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include cold and clammy skin; confusion; loss of consciousness; seizures; severe drowsiness, dizziness, or lightheadedness; slow breathing; slow heartbeat.


Proper storage of OxyIR:

Store OxyIR at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from light, heat, and moisture. Do not store in the bathroom. Keep OxyIR out of the reach of children and away from pets.


General information:


  • If you have any questions about OxyIR, please talk with your doctor, pharmacist, or other health care provider.

  • OxyIR is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about OxyIR. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More OxyIR resources


  • OxyIR Side Effects (in more detail)
  • OxyIR Use in Pregnancy & Breastfeeding
  • Drug Images
  • OxyIR Drug Interactions
  • OxyIR Support Group
  • 3 Reviews for OxyIR - Add your own review/rating


  • Dazidox Advanced Consumer (Micromedex) - Includes Dosage Information

  • OxyContin Prescribing Information (FDA)

  • Oxycodone Prescribing Information (FDA)

  • Oxycodone Monograph (AHFS DI)

  • Oxycontin Consumer Overview

  • Roxicodone Prescribing Information (FDA)



Compare OxyIR with other medications


  • Pain

Thursday, 16 June 2011

Safexin




Safexin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Safexin



Cefalexin

Cefalexin sodium salt (a derivative of Cefalexin) is reported as an ingredient of Safexin in the following countries:


  • Italy

International Drug Name Search

Monday, 6 June 2011

Strongid




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Strongid



Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Strongid in the following countries:


  • Finland

  • France

  • Ireland

  • Italy

  • Netherlands

  • Portugal

  • Switzerland

  • United Kingdom

  • United States

Pyrantel tartrate (a derivative of Pyrantel) is reported as an ingredient of Strongid in the following countries:


  • United States

International Drug Name Search

Propranolol Lek




Propranolol Lek may be available in the countries listed below.


Ingredient matches for Propranolol Lek



Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol Lek in the following countries:


  • Croatia (Hrvatska)

International Drug Name Search

Thursday, 2 June 2011

brimonidine ophthalmic


Generic Name: brimonidine ophthalmic (bri MO ni deen)

Brand names: Alphagan P, Alphagan


What is brimonidine ophthalmic?

Brimonidine reduces the amount of fluid in the eye, which decreases pressure inside the eye.


Brimonidine ophthalmic is used to treat open-angle glaucoma or ocular hypertension (high pressure inside the eye).

Brimonidine ophthalmic may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about brimonidine ophthalmic?


Do not use brimonidine ophthalmic if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days.

Before using brimonidine ophthalmic, tell your doctor if you have kidney or liver disease, heart disease, high blood pressure, circulation problems such as Raynaud's or Buerger's disease, or a history of fainting or low blood pressure.


Do not use this medication while you are wearing contact lenses. This medication may contain a preservative that can be absorbed by soft contact lenses. Wait at least 15 minutes after using brimonidine before putting your contact lenses in.

Do not allow the dropper tip to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.


What should I discuss with my healthcare provider before using brimonidine ophthalmic?


You should not use this medication if you are allergic to brimonidine.


Do not use brimonidine ophthalmic if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days.

Before using brimonidine ophthalmic, tell your doctor if you have:


  • kidney disease;

  • liver disease;


  • heart disease or high blood pressure;




  • circulation problems, such as Raynaud's syndrome or Buerger's disease; or




  • a history of fainting or low blood pressure.



If you have any of these conditions, you may need a dose adjustment or special tests to safely use brimonidine ophthalmic.


FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether brimonidine ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use brimonidine ophthalmic?


Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


Wash your hands before using the eye drops.


Do not use this medication while you are wearing contact lenses. This medication may contain a preservative that can be absorbed by soft contact lenses. Wait at least 15 minutes after using brimonidine before putting your contact lenses in.

To apply the eye drops:



  • Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the dropper above the eye with the dropper tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.




  • Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct.




  • If you use any other eye medications, wait about 5 minutes after using brimonidine eye drops before using the other medication.




  • Do not allow the dropper tip to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.



Do not use the eye drops if the liquid has changed colors or has particles in it. Call your doctor for a new prescription.


Store the drops at room temperature away from heat and moisture. Keep the bottle tightly closed when not in use.


What happens if I miss a dose?


Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and wait until your next regularly scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine, or if anyone has accidentally swallowed it. An overdose of brimonidine ophthalmic is unlikely to cause life-threatening side effects.

What should I avoid while using brimonidine ophthalmic?


Brimonidine can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid using any eye medications your doctor has not prescribed. Cold or allergy medicine, narcotic pain medicine, sleeping pills, sedatives, and medicine for seizures can add to sleepiness caused by brimonidine ophthalmic. Tell your doctor if you regularly use any of these medicines.

Brimonidine ophthalmic side effects


Stop using brimonidine and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

  • slow or uneven heart rate;




  • pounding heartbeats or fluttering in your chest;




  • shallow breathing, feeling like you might pass out;




  • severe swelling, redness, or discomfort in or around your eye;




  • eye pain or increased watering; or




  • numbness or tingly feeling in your hands or feet.



Less serious side effects may include:



  • burning, stinging, or itching of your eyes;




  • feeling like something is in your eye;




  • blurred vision;




  • redness of the eye or eyelid;




  • mildly swollen or puffy eyes;




  • sensitivity to light;




  • nausea, upset stomach;




  • headache, dizziness;




  • muscle pain;




  • tired feeling;




  • sleep problems (insomnia);




  • dry nose or mouth; or




  • unusual or unpleasant taste in your mouth.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


Brimonidine ophthalmic Dosing Information


Usual Adult Dose for Intraocular Hypertension:

1 drop in the affected eye every 8 hours

Usual Adult Dose for Glaucoma (Open Angle):

1 drop in the affected eye every 8 hours

Usual Pediatric Dose for Intraocular Hypertension:

>= 2 years: 1 drop in the affected eye every 8 hours

Usual Pediatric Dose for Glaucoma (Open Angle):

>= 2 years: 1 drop in the affected eye every 8 hours


What other drugs will affect brimonidine ophthalmic?


Before using brimonidine ophthalmic, tell your doctor if you are using any of the following medications:



  • blood pressure medications;




  • digoxin (digitalis, Lanoxin);




  • a beta-blocker such as atenolol (Tenormin), betaxolol (Betoptic, Kerlone), bisoprolol (Zebeta), carteolol (Cartrol, Ocupress), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), timolol (Betimol, Blocadren, Cosopt, Timoptic, Istalol), and others; or




  • antidepressants such as amitriptyline (Elavil, Etrafon), doxepin (Sinequan), imipramine (Janimine, Tofranil), nortriptyline (Pamelor), and others.



This list is not complete and there may be other drugs that can interact with brimonidine ophthalmic. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More brimonidine ophthalmic resources


  • Brimonidine ophthalmic Side Effects (in more detail)
  • Brimonidine ophthalmic Dosage
  • Brimonidine ophthalmic Use in Pregnancy & Breastfeeding
  • Brimonidine ophthalmic Drug Interactions
  • Brimonidine ophthalmic Support Group
  • 3 Reviews for Brimonidine - Add your own review/rating


  • Alphagan Consumer Overview

  • Alphagan P Prescribing Information (FDA)

  • Alphagan P Monograph (AHFS DI)

  • Alphagan P Advanced Consumer (Micromedex) - Includes Dosage Information

  • Alphagan P MedFacts Consumer Leaflet (Wolters Kluwer)



Compare brimonidine ophthalmic with other medications


  • Glaucoma, Open Angle
  • Intraocular Hypertension


Where can I get more information?


  • Your pharmacist can provide more information about brimonidine ophthalmic.

See also: brimonidine side effects (in more detail)


Thursday, 5 May 2011

Ferbisol




Ferbisol may be available in the countries listed below.


Ingredient matches for Ferbisol



Ferrous Glycine Sulfate

Ferrous Glycine Sulfate is reported as an ingredient of Ferbisol in the following countries:


  • Spain

International Drug Name Search

Wednesday, 4 May 2011

Valontan




Valontan may be available in the countries listed below.


Ingredient matches for Valontan



Dimenhydrinate

Dimenhydrinate is reported as an ingredient of Valontan in the following countries:


  • Italy

International Drug Name Search

Brompheniramine Maleate




Ingredient matches for Brompheniramine Maleate



Brompheniramine

Brompheniramine Maleate (BANM) is known as Brompheniramine in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 3 May 2011

Gen-Buspirone




Gen-Buspirone may be available in the countries listed below.


Ingredient matches for Gen-Buspirone



Buspirone

Buspirone is reported as an ingredient of Gen-Buspirone in the following countries:


  • Canada

International Drug Name Search

Thursday, 28 April 2011

Levolam




Levolam may be available in the countries listed below.


Ingredient matches for Levolam



Levomepromazine

Levomepromazine maleate (a derivative of Levomepromazine) is reported as an ingredient of Levolam in the following countries:


  • Argentina

International Drug Name Search

Tuesday, 26 April 2011

Vetothane




Vetothane may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vetothane



Halothane

Halothane is reported as an ingredient of Vetothane in the following countries:


  • United Kingdom

International Drug Name Search

Thursday, 14 April 2011

Apatya




Apatya may be available in the countries listed below.


Ingredient matches for Apatya



Isosorbide Dinitrate

Isosorbide Dinitrate is reported as an ingredient of Apatya in the following countries:


  • Japan

International Drug Name Search

Wednesday, 13 April 2011

RiaSTAP


Pronunciation: fye-BRIN-oh-jen
Generic Name: Fibrinogen Concentrate (Human)
Brand Name: RiaSTAP


RiaSTAP is used for:

Treating bleeding in patients with congenital fibrinogen deficiency (eg, afibrinogenemia, hypofibrinogenemia).


RiaSTAP is a hematological agent. It works by replacing a certain protein in the blood that helps with blood clotting.


Do NOT use RiaSTAP if:


  • you are allergic to any ingredient in RiaSTAP

Contact your doctor or health care provider right away if any of these apply to you.



Before using RiaSTAP:


Some medical conditions may interact with RiaSTAP. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with RiaSTAP. However, no specific interactions with RiaSTAP are known at this time.


Ask your health care provider if RiaSTAP may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use RiaSTAP:


Use RiaSTAP as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • RiaSTAP is usually given as an injection at your doctor's office, hospital, or clinic.

  • Do not use RiaSTAP if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • If you miss a dose of RiaSTAP, contact your doctor right away.

Ask your health care provider any questions you may have about how to use RiaSTAP.



Important safety information:


  • RiaSTAP contains albumin, which comes from human blood. There is a very rare risk of getting a viral disease or a central nervous system disease called Creutzfeldt-Jakob disease from products with albumin. No cases of these problems have been found in patients who have used RiaSTAP.

  • Blood clots may occur unexpectedly in patients with fibrinogen deficiency. This may occur with or without use of RiaSTAP. Contact your doctor right away if you experience signs of a blood clot (eg, chest pain, leg pain or swelling, trouble breathing, or coughing up blood).

  • Lab tests, including fibrinogen levels, may be performed while you use RiaSTAP. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use RiaSTAP with caution in the ELDERLY; they may be more sensitive to its effects.

  • RiaSTAP should be used with extreme caution in CHILDREN younger than 16 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using RiaSTAP while you are pregnant. It is not known if RiaSTAP is found in breast milk. If you are or will be breast-feeding while you use RiaSTAP, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of RiaSTAP:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Headache; nausea; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chills; fever; symptoms of a blood clot (eg, chest pain; confusion; coughing up blood; fainting; numbness of arms or legs; one-sided weakness, slurred speech, mental changes; pain, numbness, or swelling of an arm or leg; sudden, severe headache or vomiting; shortness of breath).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: RiaSTAP side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of RiaSTAP:

RiaSTAP is usually handled and stored by a health care provider. If you are using RiaSTAP at home, store RiaSTAP as directed by your pharmacist or health care provider.


General information:


  • If you have any questions about RiaSTAP, please talk with your doctor, pharmacist, or other health care provider.

  • RiaSTAP is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about RiaSTAP. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More RiaSTAP resources


  • RiaSTAP Side Effects (in more detail)
  • RiaSTAP Use in Pregnancy & Breastfeeding
  • RiaSTAP Support Group
  • 0 Reviews for RiaSTAP - Add your own review/rating


  • RiaSTAP Prescribing Information (FDA)

  • RiaSTAP Monograph (AHFS DI)

  • RiaSTAP Consumer Overview



Compare RiaSTAP with other medications


  • Congenital Fibrinogen Deficiency

Friday, 1 April 2011

Gastronol




Gastronol may be available in the countries listed below.


Ingredient matches for Gastronol



Omeprazole

Omeprazole is reported as an ingredient of Gastronol in the following countries:


  • Venezuela

International Drug Name Search

Sunday, 27 March 2011

Erycoli




Erycoli may be available in the countries listed below.


Ingredient matches for Erycoli



Colistin Sulfate

Colistin sulphomethate sodium (a derivative of Colistin) is reported as an ingredient of Erycoli in the following countries:


  • Japan

Erythromycin

Erythromycin lactobionate (a derivative of Erythromycin) is reported as an ingredient of Erycoli in the following countries:


  • Japan

International Drug Name Search

Tuesday, 22 March 2011

Noxtal




Noxtal may be available in the countries listed below.


Ingredient matches for Noxtal



Brotizolam

Brotizolam is reported as an ingredient of Noxtal in the following countries:


  • Japan

International Drug Name Search

Monday, 14 March 2011

Calmasel




Calmasel may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Calmasel



Calcium Chloride

Calcium Chloride dihydrate (a derivative of Calcium Chloride) is reported as an ingredient of Calmasel in the following countries:


  • Germany

Magnesium Chloride

Magnesium Chloride hexahydrate (a derivative of Magnesium Chloride) is reported as an ingredient of Calmasel in the following countries:


  • Germany

International Drug Name Search

Thursday, 10 March 2011

Gentatrim




Gentatrim may be available in the countries listed below.


Ingredient matches for Gentatrim



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentatrim in the following countries:


  • Israel

International Drug Name Search

Saturday, 26 February 2011

Gemcirena




Gemcirena may be available in the countries listed below.


Ingredient matches for Gemcirena



Gemcitabine

Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemcirena in the following countries:


  • France

International Drug Name Search

Friday, 25 February 2011

Presdeten




Presdeten may be available in the countries listed below.


Ingredient matches for Presdeten



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Presdeten in the following countries:


  • Spain

International Drug Name Search

Monday, 21 February 2011

Ginoderm




Ginoderm may be available in the countries listed below.


Ingredient matches for Ginoderm



Estradiol

Estradiol is reported as an ingredient of Ginoderm in the following countries:


  • Chile

  • Peru

International Drug Name Search

Tobramycine CF




Tobramycine CF may be available in the countries listed below.


Ingredient matches for Tobramycine CF



Tobramycin

Tobramycin sulfate (a derivative of Tobramycin) is reported as an ingredient of Tobramycine CF in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 8 February 2011

Troclosene




In some countries, this medicine may only be approved for veterinary use.

Scheme

DCF

CAS registry number (Chemical Abstracts Service)

0002782-57-2

Chemical Formula

C3-H-Cl2-N3-O3

Molecular Weight

197

Therapeutic Categories

Disinfectant

Dermatological agent: Topical antiseptic

Chemical Name

1,3-Dichloro-1,3,5-triazine-2,4,6(1H,3H,5H)-trione

Foreign Names

  • Troclosenum (Latin)
  • Troclosen (German)
  • Troclosène (French)
  • Trocloseno (Spanish)

Generic Names

  • Troclosène (OS: DCF)
  • ACL 70 (IS)
  • AI3-25257 (IS)
  • Caswell No. 327 (IS)
  • CCRIS 4787 (IS)
  • CDB 60 (IS)
  • EPA Pesticide Chemical Code 081401 (IS)
  • Fi Clor 71 (IS)
  • Hilite 60 (IS)
  • HSDB 5897 (IS)
  • Orced (IS)
  • Troclosene Anion (IS)
  • Natriumdichlorisocyanat (IS)
  • Sodium dichloroisocyanurate (IS)
  • Sodium dichloro-s-triazinetrione (IS)

Brand Names

  • Taharsept
    Medentech, Israel


  • Agrisept (veterinary use)
    Medentech Ltd, Luxembourg


  • Klor-De
    Medentech, Israel


  • Klorsept
    Medentech, Israel


  • Taharmayim
    Medentech, Israel


  • Tahartaf
    Medentech, Israel

International Drug Name Search

Glossary

DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 7 February 2011

Lamictal D.A.C.




Lamictal D.A.C. may be available in the countries listed below.


Ingredient matches for Lamictal D.A.C.



Lamotrigine

Lamotrigine is reported as an ingredient of Lamictal D.A.C. in the following countries:


  • Iceland

International Drug Name Search

Sunday, 23 January 2011

Amlodipino MK




Amlodipino MK may be available in the countries listed below.


Ingredient matches for Amlodipino MK



Amlodipine

Amlodipine is reported as an ingredient of Amlodipino MK in the following countries:


  • Belize

  • Costa Rica

  • Dominican Republic

  • Ecuador

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipino MK in the following countries:


  • Colombia

International Drug Name Search

Thursday, 20 January 2011

Aceclofenaco Cuve




Aceclofenaco Cuve may be available in the countries listed below.


Ingredient matches for Aceclofenaco Cuve



Aceclofenac

Aceclofenac is reported as an ingredient of Aceclofenaco Cuve in the following countries:


  • Spain

International Drug Name Search

Cextil




Cextil may be available in the countries listed below.


Ingredient matches for Cextil



Cefuroxime

Cefuroxime is reported as an ingredient of Cextil in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday, 18 January 2011

Cetonil




Cetonil may be available in the countries listed below.


Ingredient matches for Cetonil



Ketoconazole

Ketoconazole is reported as an ingredient of Cetonil in the following countries:


  • Argentina

Sibutramine

Sibutramine hydrochloride monohydrate (a derivative of Sibutramine) is reported as an ingredient of Cetonil in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Nicaragua

International Drug Name Search

Thursday, 13 January 2011

Lyramycin




Lyramycin may be available in the countries listed below.


Ingredient matches for Lyramycin



Gentamicin

Gentamicin is reported as an ingredient of Lyramycin in the following countries:


  • Romania

International Drug Name Search

D.B.I.




D.B.I. may be available in the countries listed below.


Ingredient matches for D.B.I.



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of D.B.I. in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 12 January 2011

Negopen




Negopen may be available in the countries listed below.


Ingredient matches for Negopen



Ampicillin

Ampicillin is reported as an ingredient of Negopen in the following countries:


  • Turkey

International Drug Name Search

Tuesday, 11 January 2011

Neuro-Lichtenstein




Neuro-Lichtenstein may be available in the countries listed below.


Ingredient matches for Neuro-Lichtenstein



Pyridoxine

Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Neuro-Lichtenstein in the following countries:


  • Germany

Thiamine

Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Neuro-Lichtenstein in the following countries:


  • Germany

International Drug Name Search